Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: Role of Toll stimulators in DC maturation and MV amplification

Microbes and Infection

Volumn 4, Issue 8, 2002, Pages 785-794

  Murabayashi, Nozomu ^a,b   Kurita Taniguchi, Mitsue ^a   Ayata, Minoru ^c   Matsumoto, Misako ^a   Ogura, Hisashi ^c   Seya, Tsukasa ^a,b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Human myeloid dendritic cells; Immune suppression; Measles virus receptors; Membrane cofactor protein of complement; Signaling lymphocyte activation molecule

Indexed keywords

CD150 ANTIGEN; MEMBRANE COFACTOR PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN; TOLL LIKE RECEPTOR; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE PREDISPOSITION; DYNAMICS; GENE AMPLIFICATION; LYMPHOCYTE; MEASLES VIRUS; MOLECULE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; DENDRITIC CELLS; DROSOPHILA PROTEINS; FLOW CYTOMETRY; GLYCOPROTEINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULINS; LIGANDS; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; VERO CELLS; VIRUS REPLICATION;

MEASLES VIRUS;

EID: 0036629923     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01598-8     Document Type: Article

References (47)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
2. Flores-Romo L. In vivo maturation and migration of dendritic cells. Immunology. 102:2001;255-262.
3. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. M. 179:1994;1109-1118.
4. Lutz M.B., Girolomoni G., Ricciardi-Castagnoli P. The role of cytokines in functional regulation and differentiation of dendritic cells. Immunobiology. 195:1996;431-455.
5. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
6. Rescigno M., Granucci F., Citterio S., Foti M., Ricciardi-Castagnoli P. Coordinated events during bacteria-induced DC maturation. Immunol. Today. 20:1999;200-203.
7. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
8. Medzhitov R., Janeway Jr C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
9. Nishiguchi M., Matsumoto M., Takao T., Hoshino M., Shimonishi Y., Tsuji S., Begum N.A., Takeuchi O., Akira S., Toyoshima K., Seya T. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions. J. Immunol. 166:2001;2610-2616.
10. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
11. Tsuji S., Matsumoto M., Takeuchi O., Akira S., Azuma I., Hayashi A., Toyoshima K., Seya T. Maturation of human dendritic cells by cell-wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin: involvement of Toll-like receptors. Infect. Immun. 68:2000;6883-6890.
12. Oldstone M.B.A. Virus-lymphoid cell interactions. Proc. Natl. Acad. Sci. USA. 93:1996;12756-12758.
13. Tamashiro V.G., Perez H.H., Griffin D.E. Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr. Infect. Dis. J. 6:1987;451-454.
14. Kobune F., Sakata H., Sugiura S. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:1990;700-705.
15. Furukawa K., Ayata M., Kimura M., Seto T., Matsunaga I., Murata R., Yamano T., Ogura H. Hemadsorption expressed by cloned H genes from subacute sclerosing panencephalitis (SSPE) viruses and their possible progenitor measles viruses isolated in Osaka, Japan. Microbiol. Immunol. 45:2001;59-68.
16. Kurita-Taniguchi M., Fukui A., Hazeki K., Hirano A., Tsuji S., Watanabe M., Matsumoto M., Ueda S., Seya T. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46. J. Immunol. 165:2000;5143-5152.
17. Murakami Y., Seya T., Kurita M., Nagasawa S. Molecular cloning and functional characterization of membrane cofactor protein/measles virus receptor (MCP, CD46) on Vero cells. Biol. Pharmac. Bull. 19:1996;1541-1545.
18. Sidorenko S.P., Clark E.A. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151:1993;4614-4624.
19. Seya T., Hara T., Matsumoto M., Akedo H. Quantitative analysis of membrane cofactor protein (MCP) of complement: high expression of MCP on human leukemia cell lines, which is downregulated during cell-differentiation. J. Immunol. 145:1990;238-245.
20. Trescol-Biemont M.C., Leonov S., Rabourdin-Combe C., Gerlier D. Quantification of measles virus by a virus receptor-dependent and haemagglutinin-specific T cell stimulation assay. J. Immunol. Meth. 187:1995;253-258.
21. Grosjean I., Caux C., Bella C., Berger I., Wild F., Banchereau J., Kaiserlian D. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. M. 186:1997;801-812.
22. Kurita-Taniguchi M., Hazeki K., Murabayashi N., Fukui A., Tsuji S., Matsumoto M., Toyoshima K., Seya T. Molecular assembling of CD46 in CD9, alpha3 beta1 integrin and protein tyrosine phosphatase SHP-1 in human macrophages through differentiation by GM-CSF. Molec. Immunol. 38:2001;689-700.
23. Yanagi Y., Hu H.L., Seya T., Yoshikura H. Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46. Arch. Virol. 138:1994;39-53.
24. Murakami Y., Seya T., Kurita M., Fukui A., Ueda S., Nagasawa S. Molecular cloning of membrane cofactor protein (MCP, CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a MCP is susceptible to infection by the CAM but not the Nagahata strain of the measles virus. Biochem. J. 330:1998;1351-1359.
25. Naniche D., Varior-Krishnan G., Cervon F., Wild T.F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:1993;6025-6032.
26. Dorig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305.
27. Iwata K., Seya T., Ariga H., Ueda S., Nagasawa S. Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). Biochem. J. 304:1994;169-175.
28. Tatsuo H., Ono N., Tanaka K., Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature. 406:2000;893-897.
29. Iwata K., Seya T., Yanagi Y., Pesando J.M., Johnson P.M., Okabe M., Ueda S., Ariga H., Nagasawa S. Diversity of the sites for measles virus infection and for inactivation of complement C3b and C4b on membrane cofactor protein (MCP, CD46). J. Biol. Chem. 270:1995;15148-15152.
30. Manchester M., Valsamakis A., Kaufman R., Liszewski M.K., Alvarez J., Atkinson J.P., Lublin D.M., Oldstone M.B.A. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc. Natl. Acad. Sci. USA. 92:1995;2303-2307.
31. Marie J.C., Kehren J., Trescol-Biemont M.C., Evlashev A., Valentin H., Walzer T., Tedone R., Loveland B., Nicolas J.F., Rabourdin-Combe C., Horvat B. Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity. 14:2001;69-79.
32. Aversa G., Carballido J., Punnonen J., Chang C.C., Hauser T., Cocks B.G., De Vries J.E. SLAM and its role in T cell activation and Th cell responses. Immunol. Cell Biol. 75:1997;202-205.
33. Astier A., Trescol-Biemont M.C., Azocar O., Lamouille B., Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 164:2000;6091-6095.
34. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., Fenton M.J. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:1999;3920-3927.
35. Schnorr J.J., Xanthakos S., Keikavoussi P., Kampgen E., ter Meulen V., Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. USA. 94:1997;5326-5331.
36. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M.C., Liu Y.J., Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. M. 186:1997;813-823.
37. Kruse M., Rosorius O., Kratzer F., Bevec D., Kuhnt C., Steinkasserer A., Schuler G., Hauber J. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J. Exp. M. 191:2000;1581-1590.
38. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., De Vries J.E., Aversa G., Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:1998;462-469.
39. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:2001;732-738.
40. Matsumoto M., Kikkawa S., Kohase M., Miyake K., Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293:2002;1364-1369.
41. Schneider-Schaulies J., Schnorr J.J., Brinckmann U., Dunster L.M., Baczko K., Liebert U.G., Schneider-Schaulies S., ter Meulen V. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc. Natl. Acad. Sci. USA. 92:1995;3943-3947.
42. Manchester M., Eto D.S., Valsamakis A., Liton P.B., Fernandez-Munoz R., Rota P.A., Bellini W.J., Forthal D.N., Oldstone M.B.A. Clinical isolates of measles virus use CD46 as a cellular receptor. J. Virol. 74:2000;3967-3974.
43. Erlenhoefer C., Wurzer W.J., Loeffler S., Schneider-Schaulies S., ter Meulen V. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J. Virol. 75:2001;4499-4505.
44. Blau D.M., Compans R.W. Adaptation of measles virus to polarized epithelial cells: alterations in virus entry and release. Virology. 231:1997;281-289.
45. Hirano A., Yang Z., Katayama Y., Korte-Sarfaty J., Wong T.C. Human CD46 enhances nitric oxide production in mouse macrophages in response to measles virus infection in the presence of gamma interferon: dependence on the CD46 cytoplasmic domains. J. Virol. 73:1999;4776-4785.
46. Kruse M., Meinl E., Henning G., Kuhnt C., Berchtold S., Berger T., Schuler G., Steinkasserer A. Signaling lymphocytic activation molecule is expressed on mature cd83(+) dendritic cells and is upregulated by il-1beta. J. Immunol. 167:2001;1989-1995.
47. Bleharski J.R., Niazi K.R., Sieling P.A., Cheng G., Modlin R.L. Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J. Immunol. 167:2001;3174-3181.